PRC
AMED

Pearl River Capital’s Amedisys AMED Stock Holding History

Pearl River Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,405
Closed -$589K – 393
2021
Q2 		$589K Sell
2,405
-483
-17% -$127K 0.16% 191
2021
Q1 		$765K Sell
2,888
-1,370
-32% -$386K 0.24% 134
2020
Q4 		$1.25M Sell
4,258
-447
-10% -$115K 0.45% 68
2020
Q3 		$1.11M Buy
+4,705
New +$1.07M 0.47% 62
2020
Q2 		– Sell
-99
Closed -$18K – 285
2020
Q1 		$18K Buy
+99
New +$17.6K 0.03% 334

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Pearl River Capital's AMED Position: Q3 2021 in Review

Pearl River Capital sold out of Amedisys (AMED) in Q3 2021, closing a stake of 2,405 shares — an estimated $589K sold.

Pearl River Capital first reported a position in AMED in Q1 2020 and held it in 5 quarters. The position peaked at $1.25M in Q4 2020. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Pearl River Capital reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Pearl River Capital sold 2,405 Amedisys shares in Q3 2021, an estimated $589K.
  • Pearl River Capital first reported a position in Amedisys in Q1 2020 and held it in 5 quarters.
  • Pearl River Capital's Amedisys position peaked at $1.25M in Q4 2020.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Pearl River Capital's 13F filing for Q3 2021, filed 12 Nov 2021.